AN2 Therapeutics (ANTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist

1.670
+0.300+21.90%

Close Nov 29 13:00 ET

1.610
-0.060-3.59%

Post 16:53 ET

49.90MMarket Cap-839P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Recursion Pharmaceuticals (RXRX) and AN2 Therapeutics, Inc. (ANTX)
TipRanksNov 25 01:00 ET · Ratings
Insider Spends US$213k Buying More Shares In AN2 Therapeutics
Simply Wall StNov 23 07:55 ET
Insider Purchase: Director at $ANTX (ANTX) Buys 5,000 Shares
Quiver QuantitativeNov 20 16:20 ET
Kevin Krause Named President and CEO of ArrePath
BusinesswireNov 19 08:15 ET
JMP Securities Maintains AN2 Therapeutics(ANTX.US) With Buy Rating, Maintains Target Price $5
Moomoo NewsNov 19 03:36 ET · Ratings
TD Cowen Initiates AN2 Therapeutics(ANTX.US) With Hold Rating
Moomoo NewsNov 19 03:36 ET · Ratings

Comments

NVDAvsTSLA

Yesterday 02:37

$AN2 Therapeutics (ANTX.US)$ It will be risky if it cannot climb on $1.9～2.0 in the next week. But anyway, promising. Hopefully they really have some positive results

This_Guy

Nov 29 08:11

$AN2 Therapeutics (ANTX.US)$
I am in here for swing play. Chart looks good and insiders have been loading.

Trytosaveabit

Oct 17 06:03

Update

$AN2 Therapeutics (ANTX.US)$ Reuters· 1 min ago
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (Caused by Mycobacterium Tuberculosis) and Malaria